Oppenheimer analyst Leland Gershell downgrades PLx Pharma (NASDAQ:PLXP) from Outperform to Perform.
What’s Going On With AMD Stock Friday?
Advanced Micro Devices, Inc (NASDAQ: AMD) appears set to release a new low-end graphics card, the
Oppenheimer Downgrades PLx Pharma to Perform
Oppenheimer analyst Leland Gershell downgrades PLx Pharma (NASDAQ:PLXP) from Outperform to Perform.
Related Posts
Wells Fargo Maintains Equal-Weight on Axalta Coating Sys, Raises Price Target to $26
Wells Fargo analyst Michael Sison maintains Axalta Coating Sys (NYSE:AXTA) with a Equal-Weight and raises the price target from $25 to $26.
Oppenheimer Maintains Outperform on Alphabet, Lowers Price Target to $135
Oppenheimer analyst Jason Helfstein maintains Alphabet (NASDAQ:GOOG) with a Outperform and lowers the price target from $155 to $135.
IN8bio Announces Oral Presentation Of New INB-200 Phase 1 Data In Glioblastoma To Be Presented At 2023 ASCO Annual Meeting
IN8bio, Inc. (NASDAQ:INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced an oral presentation at the upcoming 2023 American Society of Clinical